John Theurer Cancer Center At Hackensack UMC

Hackensack, New Jersey 07601

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Multiple Myeloma Clinical Trial
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 10/16/2017
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL Clinical Trial
An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study of bb21217 in Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hematologic Malignancies Clinical Trial
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Hackensack, NJ
Click here to add this to my saved trials